A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Supportive Care in Cancer

• Publication date

  2007-03-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00520-007-0242-yPMID 17372773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma

  2006cited by this paper
• Acute and delayed nausea and emesis control in pediatric oncology patients

  2006cited by this paper
• Acute emesis: moderately emetogenic chemotherapy

  2005cited by this paper
• Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy

  2005cited by this paper
• Granisetron: an update on its clinical use in the management of nausea and vomiting.

  2004cited by this paper
• A Double-Blind, Crossover, Randomized Comparison of Granisetron and Ramosetron for the Prevention of Acute and Delayed Cisplatin-Induced Emesis in Patients with Gastrointestinal Cancer: Is Patient Preference a Better Primary Endpoint?

  2003cited by this paper
• A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis.

  2003cited by this paper
• COMPARISON OF TROPISETRON AND GRANISETRON IN THE CONTROL OF NAUSEA AND VOMITING IN CHILDREN RECEIVING COMBINED CANCER CHEMOTHERAPY

  2001cited by this paper
• [Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of 2 doses].

  2000cited by this paper
• A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation.

  1999cited by this paper
• Effects of granisetron in children undergoing high-dose chemotherapy: a multi-institutional, cross-over study.

  1999cited by this paper
• Serotonin receptor antagonists in prophylaxis of acute and delayed emesis induced by moderately emetogenic, single-day chemotherapy: a randomized study.

  1999cited by this paper
• Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

  1999cited by this paper
• ASHP Therapeutic Guidelines on the Pharmacologic Management of Nausea and Vomiting in Adult and Pediatric Patients Receiving Chemotherapy or Radiation Therapy or Undergoing Surgery.

  1999cited by this paper
• A randomised dose-comparison trial of granisetron in preventing emesis in children with leukaemia receiving emetogenic chemotherapy.

  1999influential reference
• Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy

  1998cited by this paper
• 5-HT3 Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting

  1998cited by this paper
• Consensus Proposal for 5-HT3 Antagonists in the Prevention of Acute Emesis Related to Highly Emetogenic Chemotherapy

  1998cited by this paper
• Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists.

  1997cited by this paper
• Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.

  1996cited by this paper
• Advances in supportive care.

  1996cited by this paper
• A randomized comparison of intravenously administered granisetron versus chlorpromazine plus dexamethasone in the prevention of ifosfamide-induced emesis in children.

  1995cited by this paper
• Granisetron as antiemetic therapy in children with cancer.

  1995influential reference
• Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.

  1995cited by this paper
• Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. The Granisetron Study Group.

  1994cited by this paper
• Prevention of Chemotherapy‐Induced Emesis with Granisetron in Children with Malignant Diseases

  1994cited by this paper
• A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin. Granisetron Study Group.

  1994cited by this paper
• The Efficacy and Safety of Granisetron in Pediatric Cancer Patients Who Had Failed Standard Antiemetic Therapy During Anticancer Chemotherapy

  1994cited by this paper
• A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin

  1994cited by this paper
• Intravenous granisetron--establishing the optimal dose. The Granisetron Study Group.

  1992cited by this paper
• Progress in the control of acute and delayed emesis induced by cisplatin.

  1991cited by this paper
• Elevated energy expenditure in cancer patients with solid tumours.

  1991cited by this paper
• Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients.

  1991cited by this paper

• Antiemetic medications for preventing chemotherapy-induced nausea and vomiting in children: a systematic review and Bayesian network meta-analysis

  2024cites this paper
• Safety of clinical practice guideline-recommended antiemetic agents for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric patients: a systematic review and meta-analysis

  2019cites this paper
• Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

  2016cites this paper
• Randomized Double Blind T rial to Compare the Efficacy of Granisetron And Ondansetron in Controlling Emesis in Children with Acute Lymphoblastic Leukemia

  2013cites this paper
• Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients

  2013cites this paper
• Comparison of granisetron plus dexamethasone versus an antiemetic cocktail containing midazolam and diphenhydramine for chemotherapy induced nausea and vomiting in children

  2013cites this paper
• Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial

  2012cites this paper
• Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009

  2011influential citation
• Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients

  2011cites this paper
• Acute Constipation in Children Receiving Chemotherapy for Cancer

  2011cites this paper
• Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.

  2010cites this paper
• Unusual reactions to 5‐HT3 receptor antagonists in a child with rhabdomyosarcoma

  2009cites this paper
• Does granisetron eliminate the gag reflex? A crossover, double-blind, placebo-controlled pilot study.

  2009cites this paper